Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Teresa, Puertolas"'
Autor:
Maria Gonzalez-Cao, Clara Mayo de las Casas, Juana Oramas, Miguel A. Berciano-Guerrero, Luis de la Cruz, Pablo Cerezuela, Ana Arance, Eva Muñoz-Couselo, Enrique Espinosa, Teresa Puertolas, Roberto Diaz Beveridge, Sebastian Ochenduszko, Maria-Jose Villanueva, Laura Basterretxea, Lorena Bellido, Delvys Rodriguez, Begoña Campos, Clara Montagut, Ana Drozdowskyj, Miguel A. Molina, Jose Antonio Lopez-Martin, Alfonso Berrocal
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Whether intermittent strategies of delivering drugs can improve cancer patients survival is still unclear. Here, the authors reports the results of a randomized phase II clinical trial aimed to compare the efficacy and safety of two dosing regimens (
Externí odkaz:
https://doaj.org/article/bcf9c314e06143fd83f1b0b564d0166e
Autor:
José Luis Manzano, Ivan Marquez-Rodas, Cristina Carrera, Mario Mandala, Eva Muñoz-Couselo, Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, Carolina Ortiz, Roger Paredes, Daniel Podzamczer, Jose Molto, Boris Revollo, Lourdes Mateu, Sara Fancelli, Enrique Espinosa, Bonaventura Clotet, Javier Martinez-Picado, Pablo Cerezuela, Ainara Soria, Alfonso Berrocal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other tumo
Externí odkaz:
https://doaj.org/article/9b4da5993e134c378f9c571d2ea5242c
Autor:
Maria, Gonzalez-Cao, Teresa, Puertolas, Clara, Martinez-Vila, Cristina, Carrera, Cayetana, Maldonado Seral, Pedro, Rodríguez-Jiménez, Silvia, Sequero, Pablo, Cerezuela-Fuentes, Rosa, Feltes Ochoa, Eva, Muñoz, Mónica, Antoñanzas Basa, Juan, Martín-Liberal, Ainara, Soria, Juan, Francisco Rodriguez Moreno, Ivan, Marquez-Rodas, Pilar, Lopez Criado, José, Luis Manzano, Rafael, Lopez-Castro, Pablo, Ayala de Miguel, Laura, Villalobos, Salvador, Martin Algarra, Ines, Gonzalez-Barrallo, Aram, Boada, Almudena, García Castaño, Susana, Puig, Guillermo, Crespo, Pablo, Luna Fra, Cristina, Aguayo Zamora, Marta, Feito Rodríguez, Lara, Valles, Ana, Drozdowskyj, Jesús, Gardeazabal, Luis, Antonio Fernandez-Morales, Alberto, Rodrigo, Raquel, Cruz, Oriol, Yelamos, Belen, Rubio, Karmele, Mujica, Mariano, Provencio, Alfonso, Berrocal
Background The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ( GRAVID ).Methods The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f3f41e0e5a020dbbf18dbcc0d240b01
https://hdl.handle.net/10171/65982
https://hdl.handle.net/10171/65982
Autor:
Clara Mayo de las Casas, Maria Gonzalez-Cao, Sebastian Ochenduszko, Juana Oramas, Miguel Angel Molina, Eva Muñoz-Couselo, Ana Arance, Roberto Diaz Beveridge, Miguel A Berciano-Guerrero, Enrique Espinosa, Luis de la Cruz, Delvys Rodriguez, Pablo Cerezuela, Ana Drozdowskyj, L. Bellido, Clara Montagut, Teresa Puertolas, Laura Basterretxea, Jose A. Lopez-Martin, Alfonso Berrocal, Maria-Jose Villanueva, Begoña Campos
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Nature Communications
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
NATURE COMMUNICATIONS
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Nature Communications
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
NATURE COMMUNICATIONS
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Combination treatment with BRAF (BRAFi) plus MEK inhibitors (MEKi) has demonstrated survival benefit in patients with advanced melanoma harboring activating BRAF mutations. Previous preclinical studies suggested that an intermittent dosing of these d
Autor:
Niki Karachaliou, Maria Gonzalez-Cao, Guillermo Crespo, Ana Drozdowskyj, Erika Aldeguer, Ana Gimenez-Capitan, Cristina Teixido, Miguel Angel Molina-Vila, Santiago Viteri, Maria De Los Llanos Gil, Salvador Martin Algarra, Elisabeth Perez-Ruiz, Ivan Marquez-Rodas, Delvys Rodriguez-Abreu, Remedios Blanco, Teresa Puertolas, Maria Angeles Royo, Rafael Rosell
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Background: Programmed death-ligand 1 (PD-L1) may be induced by oncogenic signals or can be upregulated via interferon gamma (IFN-γ). We have explored whether the expression of IFNG, the gene encoding IFN-γ, is associated with clinical response to
Externí odkaz:
https://doaj.org/article/8ac2c8fef28b486789e2a6c0357c1a10
Autor:
Maria Gonzalez-Cao, Rafael Rosell, Salvador Martin Algarra, Teresa Puertolas, Enrique Espinosa
Publikováno v:
Annals of Translational Medicine. 11:270-270
Autor:
Lucia Trilla-Fuertes, Guillermo Prado-Vazquez, Angelo Gámez-Pozo, Rocio Lopez-Vacas, Maria Isabel Lumbreras Herrera, Virtudes Soriano, Fernando Garicano, Maria Jose Lecumberri, Maria Rodriguez, Margarita Majem, Elisabeth Perez, Maria Gonzalez-Cao, Juana Oramas, Alejandra Magdaleno, Joaquin Fra, Alfonso Martin, Monica Corral, Teresa Puertolas, Juan Angel Fresno Vara, Enrique Espinosa
Publikováno v:
Cancer Research. 82:5416-5416
Background: Prediction of response to immunotherapy remains an unmet need in the field of advanced melanoma. Methods: Computational analyses, including probabilistic graphical models, sparse k-means, and consensus cluster, were used to characterize m
Autor:
Iván Márquez-Rodas, Manuel Martín González, Eduardo Nagore, Cristina Gómez-Fernández, Jose Antonio Avilés-Izquierdo, Cayetana Maldonado-Seral, Virtudes Soriano, Margarita Majem-Tarruella, Virginia Palomar, Rocio Maseda, Alfonso Martín-Carnicero, Teresa Puertolas, Elena Godoy, Pablo Cerezuela, Maria Ochoa de Olza, Begoña Campos, Elisabeth Perez-Ruiz, Ainara Soria, Irene Gil-Arnaiz, Maria Gonzalez-Cao, Elisa Galvez, Ana Arance, Joaquin Belon, Luis de la Cruz-Merino, Salvador Martín-Algarra, Spanish Multidisciplinary Group of Melanoma (GEM)
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124239 (2015)
INTRODUCTION:Familial history of melanoma is a well-known risk factor for the disease, and 7% melanoma patients were reported to have a family history of melanoma. Data relating to the frequency and clinical and pathological characteristics of both f
Externí odkaz:
https://doaj.org/article/0c51f99874584046b7850d8c146d4283
Autor:
Ivan Marquez-Rodas, Rosa Feltes Ochoa, Teresa Puertolas, Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Almudena Garcia-Castano, Marta Feito Rodríguez, Ainara Soria, Pablo Ayala de Miguel, Pilar Lopez Criado, Jesús Gardeazabal, Aram Boada, Pablo Luna Fra, Lara Valles, Luis Antonio Fernandez-Morales, Rafael Rosell, Cristina Aguayo Zamora, Mariano Provencio, Laura Villalobos, Alberto Rodrigo, Santiago Viteri, Ana Drozdowskyj, Susana Puig, Juan Martin-Liberal, Guillermo Crespo, Alfonso Berrocal, Cayetana Maldonado-Seral, Jose Luis Manzano, Mónica Antoñanzas Basa, Pedro Rodriguez-Jimenez, Eva Muñoz-Couselo
Publikováno v:
Journal of the American Academy of Dermatology
Autor:
Pedro Rodriguez-Jimenez, Cayetana Maldonado, Alfonso Berrocal, Rosa Feltes, Juan Francisco Rodriguez-Moreno, Lara Valles, Monica Antonazas-Basa, Belen Rubio-Viqueira, Luis Antonio Fernandez-Morales, Pablo Cerezuela, Eva Muñoz-Couselo, Pablo Ayala de Miguel, Jose Luis Manzano, Mariano Provencio, Cristina Aguayo, Teresa Puertolas, Almudena Garcia-Castano, Ivan Marquez-Rodas, Ainara Soria, Marta Feito-Rodríguez, Ana Drozdowskyj, Rafael Rosell, Cristina Carrera, Pilar López-Criado, Guillermo Crespo, Susana Puig, Juan Martin-Liberal, Maria Gonzalez-Cao, Pablo Luna-Fra
Background: Covid-19 pandemic by the new coronavirus SARS-Cov-2 has produced devastating effects on the health care system, affecting also cancer patient care. Data about COVID-19 infection in cancer patients are scarce, and they point out a higher r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b6ce5a23301a12747175d01abd17b5
https://doi.org/10.1101/2020.05.19.20106971
https://doi.org/10.1101/2020.05.19.20106971